Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
20
ARDT Quote, Financials, Valuation and Earnings
Last price:
$8.97
Seasonality move
:
-18.51%
Day range:
$8.78 - $8.99
52-week range:
$8.28 - $17.34
Dividend yield:
0%
P/E ratio:
6.21x
P/S ratio:
0.20x
P/B ratio:
1.04x
Volume:
495.6K
Avg. volume:
766.1K
1-year change:
-44.18%
Market cap:
$1.3B
Revenue:
$6B
EPS (TTM):
$1.44
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ARDT
Ardent Health, Inc.
|
$1.5B | $0.42 | 1.61% | -54.63% | $13.67 |
|
CON
Concentra Group Holdings Parent, Inc.
|
$565.5M | $0.38 | 14.4% | 35.1% | $28.43 |
|
HCSG
Healthcare Services Group, Inc.
|
$460.4M | $0.20 | 6.72% | 39.48% | $21.50 |
|
SGRY
Surgery Partners, Inc.
|
$821M | $0.16 | 0.25% | 31.79% | $25.45 |
|
SRXH
SRx Health Solutions, Inc.
|
-- | -- | -- | -- | -- |
|
TOI
The Oncology Institute, Inc.
|
$122.6M | -$0.10 | 39.41% | -52.63% | $6.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ARDT
Ardent Health, Inc.
|
$8.97 | $13.67 | $1.3B | 6.21x | $0.00 | 0% | 0.20x |
|
CON
Concentra Group Holdings Parent, Inc.
|
$19.85 | $28.43 | $2.5B | 16.67x | $0.06 | 1.26% | 1.21x |
|
HCSG
Healthcare Services Group, Inc.
|
$19.64 | $21.50 | $1.4B | 36.34x | $0.00 | 0% | 0.80x |
|
SGRY
Surgery Partners, Inc.
|
$15.63 | $25.45 | $2B | -- | $0.00 | 0% | 0.60x |
|
SRXH
SRx Health Solutions, Inc.
|
$0.26 | -- | $7.2M | 0.14x | $0.00 | 0% | 0.05x |
|
TOI
The Oncology Institute, Inc.
|
$3.52 | $6.50 | $346.3M | -- | $0.00 | 0% | 0.66x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ARDT
Ardent Health, Inc.
|
64.76% | 0.976 | 99.34% | 1.42x |
|
CON
Concentra Group Holdings Parent, Inc.
|
84.73% | 0.394 | 78.98% | 1.05x |
|
HCSG
Healthcare Services Group, Inc.
|
2.72% | 0.178 | 1.17% | 3.40x |
|
SGRY
Surgery Partners, Inc.
|
69.12% | 1.133 | 83.88% | 1.34x |
|
SRXH
SRx Health Solutions, Inc.
|
13.36% | -4.480 | -- | 1.30x |
|
TOI
The Oncology Institute, Inc.
|
113.45% | -2.011 | 30.41% | 1.33x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ARDT
Ardent Health, Inc.
|
$1.5B | $21.1M | 7.77% | 19.14% | 1.34% | $93M |
|
CON
Concentra Group Holdings Parent, Inc.
|
$147.4M | $96.7M | 6.61% | 46.67% | 16.88% | $39.4M |
|
HCSG
Healthcare Services Group, Inc.
|
$102M | $45.9M | 7.75% | 8.02% | 9.88% | $70M |
|
SGRY
Surgery Partners, Inc.
|
$155.8M | $133.4M | 0.32% | 0.65% | 16.24% | $63.8M |
|
SRXH
SRx Health Solutions, Inc.
|
$2.4M | -$1.1M | -- | -- | -15.2% | $377K |
|
TOI
The Oncology Institute, Inc.
|
$17.2M | -$8.1M | -48.97% | -9486.64% | -5.9% | -$13.2M |
Ardent Health, Inc. vs. Competitors
-
Which has Higher Returns ARDT or CON?
Concentra Group Holdings Parent, Inc. has a net margin of 0.08% compared to Ardent Health, Inc.'s net margin of 8.7%. Ardent Health, Inc.'s return on equity of 19.14% beat Concentra Group Holdings Parent, Inc.'s return on equity of 46.67%.
Company Gross Margin Earnings Per Share Invested Capital ARDTArdent Health, Inc.97.52% -$0.17 $3.9B CONConcentra Group Holdings Parent, Inc.25.73% $0.37 $2.5B -
What do Analysts Say About ARDT or CON?
Ardent Health, Inc. has a consensus price target of $13.67, signalling upside risk potential of 55.13%. On the other hand Concentra Group Holdings Parent, Inc. has an analysts' consensus of $28.43 which suggests that it could grow by 43.22%. Given that Ardent Health, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe Ardent Health, Inc. is more attractive than Concentra Group Holdings Parent, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ARDTArdent Health, Inc.7 4 0 CONConcentra Group Holdings Parent, Inc.5 0 0 -
Is ARDT or CON More Risky?
Ardent Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Concentra Group Holdings Parent, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ARDT or CON?
Ardent Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Concentra Group Holdings Parent, Inc. offers a yield of 1.26% to investors and pays a quarterly dividend of $0.06 per share. Ardent Health, Inc. pays -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc. pays out 4.81% of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ARDT or CON?
Ardent Health, Inc. quarterly revenues are $1.6B, which are larger than Concentra Group Holdings Parent, Inc. quarterly revenues of $572.8M. Ardent Health, Inc.'s net income of $1.2M is lower than Concentra Group Holdings Parent, Inc.'s net income of $49.8M. Notably, Ardent Health, Inc.'s price-to-earnings ratio is 6.21x while Concentra Group Holdings Parent, Inc.'s PE ratio is 16.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ardent Health, Inc. is 0.20x versus 1.21x for Concentra Group Holdings Parent, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARDTArdent Health, Inc.0.20x 6.21x $1.6B $1.2M CONConcentra Group Holdings Parent, Inc.1.21x 16.67x $572.8M $49.8M
-
Which has Higher Returns ARDT or HCSG?
Healthcare Services Group, Inc. has a net margin of 0.08% compared to Ardent Health, Inc.'s net margin of 9.25%. Ardent Health, Inc.'s return on equity of 19.14% beat Healthcare Services Group, Inc.'s return on equity of 8.02%.
Company Gross Margin Earnings Per Share Invested Capital ARDTArdent Health, Inc.97.52% -$0.17 $3.9B HCSGHealthcare Services Group, Inc.21.98% $0.59 $509.9M -
What do Analysts Say About ARDT or HCSG?
Ardent Health, Inc. has a consensus price target of $13.67, signalling upside risk potential of 55.13%. On the other hand Healthcare Services Group, Inc. has an analysts' consensus of $21.50 which suggests that it could grow by 9.47%. Given that Ardent Health, Inc. has higher upside potential than Healthcare Services Group, Inc., analysts believe Ardent Health, Inc. is more attractive than Healthcare Services Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ARDTArdent Health, Inc.7 4 0 HCSGHealthcare Services Group, Inc.2 3 0 -
Is ARDT or HCSG More Risky?
Ardent Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Healthcare Services Group, Inc. has a beta of 0.752, suggesting its less volatile than the S&P 500 by 24.779%.
-
Which is a Better Dividend Stock ARDT or HCSG?
Ardent Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthcare Services Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ardent Health, Inc. pays -- of its earnings as a dividend. Healthcare Services Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARDT or HCSG?
Ardent Health, Inc. quarterly revenues are $1.6B, which are larger than Healthcare Services Group, Inc. quarterly revenues of $464.3M. Ardent Health, Inc.'s net income of $1.2M is lower than Healthcare Services Group, Inc.'s net income of $43M. Notably, Ardent Health, Inc.'s price-to-earnings ratio is 6.21x while Healthcare Services Group, Inc.'s PE ratio is 36.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ardent Health, Inc. is 0.20x versus 0.80x for Healthcare Services Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARDTArdent Health, Inc.0.20x 6.21x $1.6B $1.2M HCSGHealthcare Services Group, Inc.0.80x 36.34x $464.3M $43M
-
Which has Higher Returns ARDT or SGRY?
Surgery Partners, Inc. has a net margin of 0.08% compared to Ardent Health, Inc.'s net margin of 3.08%. Ardent Health, Inc.'s return on equity of 19.14% beat Surgery Partners, Inc.'s return on equity of 0.65%.
Company Gross Margin Earnings Per Share Invested Capital ARDTArdent Health, Inc.97.52% -$0.17 $3.9B SGRYSurgery Partners, Inc.18.97% -$0.18 $7.4B -
What do Analysts Say About ARDT or SGRY?
Ardent Health, Inc. has a consensus price target of $13.67, signalling upside risk potential of 55.13%. On the other hand Surgery Partners, Inc. has an analysts' consensus of $25.45 which suggests that it could grow by 62.86%. Given that Surgery Partners, Inc. has higher upside potential than Ardent Health, Inc., analysts believe Surgery Partners, Inc. is more attractive than Ardent Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ARDTArdent Health, Inc.7 4 0 SGRYSurgery Partners, Inc.8 3 0 -
Is ARDT or SGRY More Risky?
Ardent Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Surgery Partners, Inc. has a beta of 1.932, suggesting its more volatile than the S&P 500 by 93.198%.
-
Which is a Better Dividend Stock ARDT or SGRY?
Ardent Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ardent Health, Inc. pays -- of its earnings as a dividend. Surgery Partners, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARDT or SGRY?
Ardent Health, Inc. quarterly revenues are $1.6B, which are larger than Surgery Partners, Inc. quarterly revenues of $821.5M. Ardent Health, Inc.'s net income of $1.2M is lower than Surgery Partners, Inc.'s net income of $25.3M. Notably, Ardent Health, Inc.'s price-to-earnings ratio is 6.21x while Surgery Partners, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ardent Health, Inc. is 0.20x versus 0.60x for Surgery Partners, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARDTArdent Health, Inc.0.20x 6.21x $1.6B $1.2M SGRYSurgery Partners, Inc.0.60x -- $821.5M $25.3M
-
Which has Higher Returns ARDT or SRXH?
SRx Health Solutions, Inc. has a net margin of 0.08% compared to Ardent Health, Inc.'s net margin of -13.47%. Ardent Health, Inc.'s return on equity of 19.14% beat SRx Health Solutions, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ARDTArdent Health, Inc.97.52% -$0.17 $3.9B SRXHSRx Health Solutions, Inc.33.29% -$0.07 $9.2M -
What do Analysts Say About ARDT or SRXH?
Ardent Health, Inc. has a consensus price target of $13.67, signalling upside risk potential of 55.13%. On the other hand SRx Health Solutions, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ardent Health, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe Ardent Health, Inc. is more attractive than SRx Health Solutions, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ARDTArdent Health, Inc.7 4 0 SRXHSRx Health Solutions, Inc.0 0 0 -
Is ARDT or SRXH More Risky?
Ardent Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SRx Health Solutions, Inc. has a beta of 0.929, suggesting its less volatile than the S&P 500 by 7.069%.
-
Which is a Better Dividend Stock ARDT or SRXH?
Ardent Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SRx Health Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ardent Health, Inc. pays -- of its earnings as a dividend. SRx Health Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARDT or SRXH?
Ardent Health, Inc. quarterly revenues are $1.6B, which are larger than SRx Health Solutions, Inc. quarterly revenues of $7.2M. Ardent Health, Inc.'s net income of $1.2M is higher than SRx Health Solutions, Inc.'s net income of -$964K. Notably, Ardent Health, Inc.'s price-to-earnings ratio is 6.21x while SRx Health Solutions, Inc.'s PE ratio is 0.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ardent Health, Inc. is 0.20x versus 0.05x for SRx Health Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARDTArdent Health, Inc.0.20x 6.21x $1.6B $1.2M SRXHSRx Health Solutions, Inc.0.05x 0.14x $7.2M -$964K
-
Which has Higher Returns ARDT or TOI?
The Oncology Institute, Inc. has a net margin of 0.08% compared to Ardent Health, Inc.'s net margin of -10.08%. Ardent Health, Inc.'s return on equity of 19.14% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.
Company Gross Margin Earnings Per Share Invested Capital ARDTArdent Health, Inc.97.52% -$0.17 $3.9B TOIThe Oncology Institute, Inc.12.59% -$0.14 $91.3M -
What do Analysts Say About ARDT or TOI?
Ardent Health, Inc. has a consensus price target of $13.67, signalling upside risk potential of 55.13%. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 84.66%. Given that The Oncology Institute, Inc. has higher upside potential than Ardent Health, Inc., analysts believe The Oncology Institute, Inc. is more attractive than Ardent Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ARDTArdent Health, Inc.7 4 0 TOIThe Oncology Institute, Inc.3 0 0 -
Is ARDT or TOI More Risky?
Ardent Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.162, suggesting its less volatile than the S&P 500 by 83.817%.
-
Which is a Better Dividend Stock ARDT or TOI?
Ardent Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ardent Health, Inc. pays -- of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ARDT or TOI?
Ardent Health, Inc. quarterly revenues are $1.6B, which are larger than The Oncology Institute, Inc. quarterly revenues of $136.6M. Ardent Health, Inc.'s net income of $1.2M is higher than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, Ardent Health, Inc.'s price-to-earnings ratio is 6.21x while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ardent Health, Inc. is 0.20x versus 0.66x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARDTArdent Health, Inc.0.20x 6.21x $1.6B $1.2M TOIThe Oncology Institute, Inc.0.66x -- $136.6M -$13.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
